Aller au contenu principal
2025 article

Association of Age at Type 2 Diabetes Onset With Diabetes Progression

2Citations signalées — pas une note de qualité
11Institutions déclarées
3Pays d’affiliation déclarés

Résumé fourni par la source

OBJECTIVE: To examine whether age at type 2 diabetes onset affects disease progression, assessed by changes in glycemic control and clinical biomarkers during follow-up. RESEARCH DESIGN AND METHODS: Participants in the Kerala Diabetes Prevention Program (K-DPP) and U.S. Diabetes Prevention Program (US-DPP) who developed type 2 diabetes during the trial were analyzed. Data on fasting plasma glucose (FPG), hemoglobin A1c (HbA1c), triglycerides (TGs), HDL, LDL, BMI, blood pressure, and estimated glomerular filtration rate (eGFR) were collected at diabetes onset and end of follow-up. Linear and mixed-effects regressions assessed the association and rate of biomarker change by age at onset. RESULTS: We included 802 US-DPP (mean age 52.6 years) and 146 K-DPP participants (mean age 47.7 years). Younger-onset participants had a higher BMI at onset and end of follow-up (mean follow-up 7.9 and 7.6 years for US-DPP and K-DPP, respectively), with a relatively small BMI change over time in US-DPP participants. In fully adjusted models, FPG and HbA1c at onset were not associated with age at onset. Both measures increased faster in younger-onset participants, although the association was not significant in K-DPP participants. In US-DPP participants, younger age at onset was associated with higher eGFR and lower HDL and systolic blood pressure (SBP); similar directions were seen in K-DPP participants, but the association with HDL was nonsignificant. SBP fell slightly in older-onset US-DPP participants during follow-up but not in younger-onset participants. CONCLUSIONS: Younger-onset diabetes was associated with greater adiposity, lower HDL, and better SBP and eGFR at onset, with differences largely persisting during follow-up. During follow-up, glycemia increased slightly faster in individuals with younger-onset diabetes.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Association of Age at Type 2 Diabetes Onset With Diabetes Progression
Date Crossref
07/11/2025
Éditeur
American Diabetes Association
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.

Institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Sujets associés

Diabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Function and Risk FactorsDiabetes Treatment and Management

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.